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Abstract A fundamental hallmark of cancer is progression
to metastasis and the growth of breast cancer metastases in
lung, bone, liver and/or brain causes fatal complications.
Unfortunately, the cellular and biochemical mechanisms of
the metastatic process remain ill-defined. Recent application
of intravital multiphoton microscopy (MP-IVM) to image
fluorescently labeled cells in mouse models of cancer
has allowed dynamic observation of this multi-step pro-
cess at the cellular and subcellular levels. In this article,
we discuss the use of MP-IVM in studies of breast
cancer metastasis, as well as surgical techniques for
exposing tumors prior to imaging. We also describe a
versatile multiphoton microscope for imaging tumor-stroma
interactions.
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Abbreviations
MP-IVM Multiphoton intravital microscopy
MPM Multiphoton microscopy
SHG Second harmonic generation
PMT Photomultiplier tube
FLIM Fluorescence-lifetime imaging microscopy
FRET Fluorescence resonance energy transfer
Introduction
Metastases are the main cause of death in breast cancer
patients[1]. In metastasis, cancer cells from the primary
tumor migrate to and enter the blood stream directly, or
indirectly through the lymphatic system. Surviving cancer
cells transported to distant sites may then seed metastases.
Metastatic spread and growth depend on properties of the
cancer cell, its anatomical microenvironment at the primary
site (the cancer stroma, i.e., fibroblasts, immune and vascu-
lar cells and the extracellular matrix), and characteristics of
the site of metastasis[2–4]. Primary tumor end-stage meas-
urements (i.e., tumor volume) or classical biochemical
assays provide a static “snapshot” of a large population of
cancer cells, thereby obscuring the adaptive properties of the
few neoplastic cells with the capacity to escape from the
primary tumor, survive and adapt to changing environments
at distant metastatic sites. In contrast, intravital imaging
allows the study of metastatic cancer cells within the large
population of non-metastasizing cells[5–7].
The application of intravital multiphoton microscopy (MP-
IVM) allows real-time observation of many pathological pro-
cesses in four dimensions (x, y, z and time) and at a single-cell
level, including (a) tumor initiation and growth, (b) interaction
of cancer cells and the tumor stroma at the primary site, (c)
intra- and extravasation, (d) functional crosstalk between
metastatic cells and the stroma at the metastatic site, (e)
responses of cancer cells to chemotactic factors, and (f)
responses of cancer cells to anti-cancer treatments[7, 8]. Sev-
eral tools developed for visualizing changes in cellular pro-
cesses (e.g., cell death, proliferation, migration, and fate) or in
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signaling pathways (e.g., enzymatic activity) have been used
successfully in MP-IVM experiments[7–9] and have led to
new insights in cancer research[4, 7, 10, 11]. For example, use
of a chemotaxis-based in vivo invasion assay and multiphoton
microscopy has provided the first direct evidence of a para-
crine loop between macrophages and tumor cells, which is
involved in the intravasation of breast tumor cells[7, 12].
There are at least five requirements for MP-IVM exam-
ination of mammary cancer: (a) a mouse model of mammary
cancer[13] (e.g., immunocompetent transgenic mice, trans-
planted tumor cells in immunodeficient mice); (b) techni-
ques for surgical exposure and immobilization of the tumor
such that perfusion of the tissue remains intact; (c) fluores-
cent labels for the tumor and/or the stroma; (d) a multipho-
ton microscope suitable for intravital imaging; and (e) an
image-processing software for the analysis of dynamic
recordings[8, 14, 15]. In the present article, we describe a
versatile, custom-built modular multiphoton microscope for
imaging tumor-stroma interactions at both primary and
metastatic sites. We also compare surgical techniques for
exposing the tumor prior to imaging.
Multiphoton Microscope
Confocal and multiphoton microscopes have both been used to
image mammary tumors in living mice[16–19]. In confocal
microscopy, single photons of the visible spectrum excite
fluorophores from the electronic ground state to an excited
state and light is emitted as these molecules return to the
ground state (Fig. 1a). This excitation takes place throughout
a broad focal volume and to make the optical section appear
crisp, out-of-focus light is shielded from the detector by a
pinhole. In multiphoton microscopy (MPM), fluorophores
are excited when they simultaneously absorb two or more
low-energy photons of the infrared spectrum generated by a
highly focused short laser pulses (Fig. 1a). At the focal plane,
the density of the photons is such that two or more photons
interact concurrently with the same fluorophore with high
probability. Since simultaneous absorption of two photons by
fluorophores is restricted to the focal plane, this thwarts out-of-
focus excitation and emission[20] and, thus, a crisp optical
section is obtained without the need for a pinhole. Because of
the focal excitation of fluorophores, emitted light does not
travel back through the optical path of the scanner, with result-
ing losses of emission light at each optical element. Instead,
emitted fluorescence is detected close to the objective, which
greatly increases sensitivity. The localization of excitation to
the focal plane in MPM offers two additional advantages
makingMP-IVM superior to confocal microscopy for imaging
of multi-cellular tissues (e.g., mammary tumors, Fig. 1b). Pho-
tobleaching and photodamage[18, 21] are reduced and, since
there is no out-of-focus absorption, more excitation light can
penetrate the tissue to a greater depth. Furthermore, low-energy
photons of the infrared light used in MP-IVM penetrate up to
1,000μm in tissue, as compared to only <100 μm for the high-
energy photons of visible light used in confocal microscopy. A
further advantage of excitation with pulsed, coherent infrared
Figure 1 Jablonski energy diagram and a MP-IVM image of a mouse
mammary tumor. a Energy diagram showing absorption of a single
photon (1P, blue arrow) or the simultaneous absorption of 2 lower-
energy photons (2P, red arrows), which trigger excitation of the fluo-
rophore. After either of the excitation processes, part of the energy is
dissipated as heat (grey arrow) and the rest is emitted as fluorescence
(black arrow). b MP-IVM merged images of the murine breast cancer
cell line 4 T1 expressing EGFP orthotopically injected into the fourth
mammary gland of Balb/c mice. A mammary imaging window was
implanted surgically when the tumor was palpable (3 days after injec-
tion). Two days after surgery, Texas Red dextran was injected i.v. to
visualize the blood circulation (red signal), and an image of tumor cells
(green signal) was acquired through the mammary imaging window.
The image is a single optical section taken from a 100 μm z-stack using
a 20X (N.A. 0.95) objective at wave length 920 nm. Scan images of the
tissue were acquired at a 5 μm increment. Scale bar represents 50 μm
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light is the formation of second harmonic generation (SHG)
signals at fibrous structures such as collagen, which allows the
visualization of extracellular matrix components in the tumor
microenvironment.
Typical MP-IVM consists of three basic components: (a) an
excitation light source (i.e., a pulsed infrared laser); (b) a
fluorescence microscope containing galvanometer-driven mir-
rors for scanning of the tissue line by line; (c) a highly sensitive
detection system of photomultiplier tubes (PMTs) (Fig. 2a).
In our own research, we face the challenge of being able to
image both orthotopic mammary tumors and metastatic sites
such as lymph nodes or bone marrow. An upright microscope
with an objective located above the specimen is more conve-
nient for imaging the skull bone marrow[22] than an inverted
microscope with an objective below the specimen. However,
an upright microscope is not suitable for imaging orthotopic
mammary tumors or the inguinal lymph node, because the
mouse would have to rest on its back and movement caused
by breathing would result in unacceptable z-drift of the
images. To meet this challenge, we built a microscope ab
initio based on a previously published design[23], using a
commercially available kit from Sutter Inc (Fig. 2b–d). Our
MPMhas a rotating detector head for optimal imaging of bone
marrow (with an upright head, Fig. 2c) or orthotopic mam-
mary tumors and inguinal lymph nodes (with an inverted
head, Fig. 2d). In order to switch between upright and inverted
configurations without laser realignment, the axis of rotation
of the detector head is around the laser beam. The laser light
(Mai Tai Millennia, Newport Spectra physics) passes first
through a galvanometer-driven scanhead, which allows for
line-scanning acquisition of images. The light then passes
through a dichroic mirror posted in the detector head of the
microscope at 45° relative to the light path and is reflected
through the objective to the sample. This setup permits rota-
tion of the detector head without changing the light path from
the laser to the objective. For detection of the emitted fluores-
cence, we use three separate PMTs (Hamamatsu photomulti-
plier tubes R6357 multialkali) (Fig. 3). Each PMT contains a
bandpass filter that collects a specific wavelength and has an
18° angle of reflectance (Chroma, Bellows Falls, Vt., USA) to
send remaining light to the next PMT. Signals from the
microscope are acquired and converted to real-time images
by a custom-made algorithm based on Matlab (MathWorks,
Natick, Mass. USA), before being analyzed offline.
Surgical Preparation of Mice for Imaging of Primary
Tumors and Metastases
As tumor growth and metastasis are slow processes, it is
best to use surgical techniques that allow repeated imaging
sessions with the same animal over several days. The skin-
flap technique and a dorsal skinfold chamber were first used
for exposing and repetitively imaging tumors[24–27]. The
skin-flap technique involves a small incision to remove the
skin and directly expose the tumor for imaging. While this
method is suitable for single imaging sessions of ~6–24 h[7,
16, 17], some researchers have closed and then re-opened
wounds for multiple imaging sessions, although this
presents the risk of tissue inflammation[7, 27]. In contrast,
the dorsal skinfold chamber was invented as a set-up dedi-
cated to repeated imaging sessions. The chamber is
Figure 2 Schematic of the three basic components of an MPM and an
image of our versatile custom-built microscope. a Schematic of an
MPM. As an excitation light source, we use [1] a femtosecond
titanium-sapphire (Ti-Sa) laser with a tuning range of 700–1,040 nm.
From the laser, light (red arrows) travels to [2] the galvanometer-
driven scan mirrors. Next, the laser reaches [3] the detector head where
it hits a dichroic mirror. This reflects the excitation light through the
objective towards the sample. The detection system used for collecting
fluorescence emitted by the sample (green arrows) is composed of
photodetectors, including photomultiplier tubes (PMTs). b Overview
of our custom-built MPM. The box outlined in white represents the
detector head, the thin arrows indicate the PMTs and the bold arrow
shows the dichroic mirror. c Image of the detector head in the upright
position (e.g., used for imaging bone marrow). d Image of the detector
head in the inverted position for imaging mammary tumors and ingui-
nal lymph nodes
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essentially a metal frame with a glass window implanted on
the back of the animal. A disadvantage of the dorsal skinfold
chamber has been that mammary cells are grown in an
ectopic site and, therefore, only cell line-based tumor models
can be used. Moreover, the tumor volume is restricted by the
size of the chamber and loss of heat is another disad-
vantage of dorsal skinfold chamber[28]. However, the
recent development of a mammary imaging window
implanted ventrally, on top of orthotopic xenografts or
genetically-induced tumors, extends the time and the
frequency of imaging of the same animal and eliminates
heat dispersion and the risk of an inflammatory reaction
upon prolonged imaging[29].
As yet, metastatic sites such as lymph nodes and bone
marrow can be imaged only for single imaging sessions of
~6–8 h and not longitudinally in the same mouse, as imag-
ing windows for these organs do not exist. While imaging
windows for the brain are available and imaging windows
for the calvarial bone marrow seem feasible, other meta-
static sites (e.g., liver) are not currently accessible. Imaging
windows for the lung were recently developed but are not
suitable for repetitive imaging[30, 31].
Not only advanced surgery but also the development of
new fluorophores should provide new insights into the
metastatic process. To visualize orthotopically injected
mammary cancer cells and track the same cells over several
imaging sessions, photo-switchable fluorophores have been
used[29]. For example, the fluorophore Dendra2 can be
photoconverted irreversibly from green to red fluorescence
upon blue-light radiation, and has been used successfully for
quantifying and comparing the metastatic behavior of cells
in different microenvironments[29].
What is Next?
Most studies using MP-IVM imaging have described early
steps of the metastatic process within the primary site such as
stroma-tumor interaction, cell migration and intravasation. In
contrast, little is known about the behavior of breast cancer
cells at metastatic sites in the lungs, lymph nodes, liver or bone
marrow, which are not easy to expose surgically or to subject to
long-term imaging. It is hoped that future development of two
photon micro-endoscopy and of novel imaging windows will
allow metastatic site observations in four dimensions.
Short-pulse infrared lasers allowing measurement of the
fluorescent lifetime (FLIM) of fluorophores and, thus, the
discrimination of multiple fluorophores with the same color
can multiply the number of imaging channels by at least a
factor of three. FLIM has been used successfully to discrimi-
nate autofluorescence of healthy and tumorigenic tissues[5].
Furthermore, the technique can be used to measure changes in
fluorescence resonance energy transfer (FRET) of FRET-
biosensors, allowing the quantification of second messengers
(e.g., calcium), the activation status of signaling pathways
(e.g., PLC), as well as the extent of protein-protein interactions
and further cellular processes (e.g., apoptosis) in a single tumor
cell[5]. In addition, the probes and biosensors now in devel-
opment for assessing signaling pathways in situ will allow
fidelitous assessment of changes in signaling cascades within
cancer cells following interaction with the tumor stroma and/or
in response to therapies. This will ultimately increase our
understanding of the metastatic process and hopefully lead to
the identification of novel therapeutic targets in breast cancer
metastasis.
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Figure 3 PMT design for the rotating detector head microscope.
Schematic of the three PMTs arranged in a triangle. There is no beam
splitter inside and the emission beam is reflected by a system of filters
with specific bandpasses that are positioned in front of each PMT with
an 18° angle of reflectance. The emitted light (green arrow) encounters
the first PMT (A), which is optimized to allow transmittance of light in
the range of fluorophores such as GFP (500-550 nm). The light is then
reflected (blue arrow) to the second PMT (B), which is optimized for
light in the blue spectrum (435-485 nm) and used for SHG detection
and CFP. The rest of the emitted spectrum (red arrow) goes to the third
PMT (C), which is optimized for light in the red spectrum
(573-647 nm), exciting fluorophores such as mRFP and Texas red
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